Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
1 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
1 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1041
-
1042
-
1043
-
1044
-
1045
-
1046
-
1047
-
1048
-
1049
-
1050
-
1051
-
1052
-
1053
Knockdown of <i>CPT1A</i> inactivates most of fatty acid oxidation (FAO) and decreases cellular proliferation.
Published 2018“…<p>(A) Isotopologue distribution pattern of citrate in BT549 cells with scrambled small interfering RNA (siRNA) (scrambled, black) or after <i>CPT1A</i> knockdown (KD, red). …”
-
1054
<i>casy-1</i> mutants show decreased GABAergic synaptic transmission at the NMJ.
Published 2018“…Representative traces of mIPSCs and summary data for frequency and amplitude are shown. The <i>casy-1</i> mutants showed a significant decrease in mIPSCs rate compared to WT <i>C</i>. …”
-
1055
-
1056
Loss of <i>Nf1</i> increases sleep fragmentation and decreases sleep depth.
Published 2023“…<p><b>(A-C)</b> Sleep traits of <i>nf1</i><sup>P1</sup> mutants, heterozygotes, and their respective control. …”
-
1057
-
1058
Annual treatment frequencies in recurrence and non-recurrence groups.
Published 2025“…Mean outpatient visits in the recurrence group decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, p < 0.001). …”
-
1059
-
1060
Annual treatment frequencies in all eyes.
Published 2025“…<p>The number of anti-VEGF treatments, STTA, MA-PC, PPV, and total treatments (mean ± SD) significantly decreased from 2.6 ± 1.6, 0.3 ± 0.8, 0.6 ± 0.8, 0.1 ± 0.3, and 3.7 ± 1.7 preoperatively to 0.8 ± 1.9, 0.0 ± 0.2, 0.3 ± 1.0, 0.0, and 1.2 ± 2.2; at year 2 to 0.7 ± 2.0, 0.1 ± 0.6, 0.0 ± 0.2, 0.0 ± 0.2, and 1.0 ± 2.1; and at year 3 to 0.9 ± 2.2, 0.0, 0.2 ± 1.0, 0.0 ± 0.2, and 1.1 ± 3.1 (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”